Hospitals Segment to Lead Organ Care Products Market During 2021-2028
According to the latest study on 'Organ Care Products Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Modality, Organ Type, and End User,' the market size is expected to grow from US$ 98.46 million in 2021 to US$ 272.16 million by 2028; it is estimated to grow at a CAGR of 15.6% from 2021 to 2028. The report highlights the key factors and trends impacting the market and focuses on prominent players and their strategies.
An organ care product is a medical device used to preserve donor organs for longer periods before transplantation. These procedures allow the transplant team to ensure that transplant organs function optimally. It is a technique for keeping transplanted or donor organs at a safe temperature. 'Heart in a box' is another name for this technique. Before being transplanted, organs of interest are kept in the best possible condition and are entirely manageable. The approach confers with the traditional systems of preserving organs by freezing or running them in an environment and condition comparable to that of the human body by perfusing the donor's blood via the organs. Organs like the kidney, liver, heart, and lungs can be monitored from this technology to ensure that they function at their best.
The increase in the incidence of organ failures and transplant procedures and new product launches and product approvals in organ care products propel the organ care products market growth. However, the high cost of organ transplantation and cultural barriers limit organ care products market growth.
Based on end user, the organ care products market is segmented into hospitals, ambulatory surgical centers, and others. The hospitals segment held the largest share of the organ care products market in 2021. Moreover, the same segment is expected to register the highest CAGR during the forecast period. The increasing incidence of organ failure leading to organ transplants, surging adoption of advanced technology, developing healthcare infrastructure, and rising healthcare expenditure are factors contributing to the growth of the hospital segment. Additionally, kidney transplants are the most common type of transplant surgery; while the least common single-organ transplants are of intestines. UNOS administers the Organ Procurement and Transplantation Network, which includes the organ transplant waiting list. Organ transplants include kidney, pancreas, liver, and among others. Sometimes, 'double' transplants are also done, such as kidney/pancreas or heart/lung. According to the UNOS data, in the US, 9 types of organ transplants are performed. Moreover, in 2021, more than 40,000 organ transplants were performed in the US where most recipients were between the ages of 50 and 64. Hospitals are an essential element of America's health care system and surgeons performed more than 36,000 organ transplants in 2018. Turkey is one of the most sought-after destinations and has emerged as a hub for organ transplantation, due to the high success and survival rate of the live kidney transplant programs. Patients from around the world, visit top kidney transplant hospitals in Turkey for their treatment.
TransMedics; XVIVO Perfusion; Bridge to Life Ltd; Paragonix Technologies, Inc.; OrganOx Limited; Waters Medical Systems LLC; Organ Recovery Systems; Accord Healthcare; Dr. Franz Koehler Chemie GmbH; and Preservation Solutions, Inc. are among the key players operating in the organ care products market.
The organ care products market is analyzed based on modality, organ type, end user, and geography. Based on modality, the market is categorized into trolley and portable. Based on organ type, the organ care products market is segmented into kidney, liver, heart, lungs, and others. Based on end user, the organ care products market is categorized into hospitals, ambulatory surgical centers, and others. By geography, the market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of the Middle East & Africa), and South and Central America (Brazil, Argentina, and the Rest of South & Central America).
Reasons to Buy
According to the latest study on 'Organ Care Products Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Modality, Organ Type, and End User,' the market size is expected to grow from US$ 98.46 million in 2021 to US$ 272.16 million by 2028; it is estimated to grow at a CAGR of 15.6% from 2021 to 2028. The report highlights the key factors and trends impacting the market and focuses on prominent players and their strategies.
An organ care product is a medical device used to preserve donor organs for longer periods before transplantation. These procedures allow the transplant team to ensure that transplant organs function optimally. It is a technique for keeping transplanted or donor organs at a safe temperature. 'Heart in a box' is another name for this technique. Before being transplanted, organs of interest are kept in the best possible condition and are entirely manageable. The approach confers with the traditional systems of preserving organs by freezing or running them in an environment and condition comparable to that of the human body by perfusing the donor's blood via the organs. Organs like the kidney, liver, heart, and lungs can be monitored from this technology to ensure that they function at their best.
The increase in the incidence of organ failures and transplant procedures and new product launches and product approvals in organ care products propel the organ care products market growth. However, the high cost of organ transplantation and cultural barriers limit organ care products market growth.
Based on end user, the organ care products market is segmented into hospitals, ambulatory surgical centers, and others. The hospitals segment held the largest share of the organ care products market in 2021. Moreover, the same segment is expected to register the highest CAGR during the forecast period. The increasing incidence of organ failure leading to organ transplants, surging adoption of advanced technology, developing healthcare infrastructure, and rising healthcare expenditure are factors contributing to the growth of the hospital segment. Additionally, kidney transplants are the most common type of transplant surgery; while the least common single-organ transplants are of intestines. UNOS administers the Organ Procurement and Transplantation Network, which includes the organ transplant waiting list. Organ transplants include kidney, pancreas, liver, and among others. Sometimes, 'double' transplants are also done, such as kidney/pancreas or heart/lung. According to the UNOS data, in the US, 9 types of organ transplants are performed. Moreover, in 2021, more than 40,000 organ transplants were performed in the US where most recipients were between the ages of 50 and 64. Hospitals are an essential element of America's health care system and surgeons performed more than 36,000 organ transplants in 2018. Turkey is one of the most sought-after destinations and has emerged as a hub for organ transplantation, due to the high success and survival rate of the live kidney transplant programs. Patients from around the world, visit top kidney transplant hospitals in Turkey for their treatment.
TransMedics; XVIVO Perfusion; Bridge to Life Ltd; Paragonix Technologies, Inc.; OrganOx Limited; Waters Medical Systems LLC; Organ Recovery Systems; Accord Healthcare; Dr. Franz Koehler Chemie GmbH; and Preservation Solutions, Inc. are among the key players operating in the organ care products market.
The report segments the organ care products market as follows:
The organ care products market is analyzed based on modality, organ type, end user, and geography. Based on modality, the market is categorized into trolley and portable. Based on organ type, the organ care products market is segmented into kidney, liver, heart, lungs, and others. Based on end user, the organ care products market is categorized into hospitals, ambulatory surgical centers, and others. By geography, the market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of the Middle East & Africa), and South and Central America (Brazil, Argentina, and the Rest of South & Central America).
Reasons to Buy
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the global organ care products market
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the global organ care products market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution
Table of Contents
1. Introduction
3. Research Methodology
4. Organ Care Products Market - Market Landscape
5. Global Organ Care Products Market - Key Market Dynamics
6. Organ Care Products Market- Global Analysis
7. Global Organ Care Products Market Revenue and Forecasts To 2028- by Modality
8. Organ Care Products Market Revenue and Forecasts To 2028- By Organ Type
9. Organ Care Products Market Analysis - By End User
10. Organ Care Products Market- Geographical Analysis
11. Impact Of COVID-19 Pandemic on Organ Care Products Market
12. Organ Care Products Market -Industry Landscape
13. Company Profiles
14. Appendix
List of Tables
List of Figures
Executive Summary
The global organ care products market is expected to grow from US$ 98.46 million in 2021 to US$ 272.16 million by 2028; it is estimated to grow at a CAGR of 15.6% from 2021 to 2028.The increase in organ failures and transplant procedures and new product launches and product approvals fuel the demand for organ care products. However, the high cost of organ transplantation and cultural barriers hampers the market growth.
Organ care products are medical devices designed to store donated organs for longer periods while still providing the organ with the necessary nutrients. This device uses to keep organs safe for a set amount of time. Organs must be kept in the best possible condition and be completely manageable before being transplanted. This technology preserves transplant/donor organs at a suitable temperature. 'Heart in a box' is another name for this technique. This technology assists in monitoring organs such as kidneys, liver, heart, and lungs to ensure that they are functioning at their best. Organ care products contain one or more pump units, thermo units, and trolleys.
There has been a constant increase in organ failure incidence across the globe, owing to various chronic health conditions such as cardiovascular disorders (CVD), genetic conditions, and diabetes. As per Health Resources and Service Administration report 2020, 106,247 people, including men, women, and children, are on the national transplant waiting list. Every 9 minutes, another person is added to the transplant list in the US. Thus, the rising incidence of organ failure has created the demand for organ transplant procedures, which, in turn, will drive the organ care products market. Over the period, there has been a significant increase in organ donation, owing to rising awareness among people and rapidly developing health facilities globally. As per the Global Observatory on Donation and Transplantation, ~129,681 organ transplantations were performed globally in 2020.
On the other hand, timing, storage, and transportation have an important role in transplant procedures, especially in the case of circulatory death. Timely removal of organs, transportation, and implantation are expected to increase the success rates; this requires efficient organ care products to keep the organ safe until implantation. For this purpose, several market players such as TransMedics and OrganOx Limited have designed various systems with advanced technology to keep the organs safe, eliminating the use of organ transport cooler boxes. Thus, the increasing incidence of organ failure and growing number of people on the waiting list will drive the demand for organ care products.
Based on organ type, the organ care products market is segmented into kidney, liver, heart, lungs, and others. The kidney segment held the largest share of the market in 2021. However, the lungs segment is anticipated to register the highest CAGR during the forecast period. More than 80 million people in the US are at substantial risk of kidney failure, as per the National Kidney Foundation. The people with kidney disease and transplant recipients are at high risk of developing severe complications from COVID-19. In 2020, coronavirus infection that exploits kidney patients became the number one cause of mortality in the U.S. The increasing incidence of kidney failure leads to a massive number of patients on waiting list. In 2020, nearly 91,099 patients required kidney transplants in the US, as per the data by Health Resources & Services Administration. According to the National Institute of Diabetes and Digestive and Kidney Diseases, about 661,000 Americans have kidney failure and 193,000 have undergone kidney transplantation. 22.8 kidney transplants procedures were carried out per million population in 2020 in Germany. Therefore, various organ care products were developed by market players in order to provide better care to the customers suffering from kidney failure and require transplantation. For instance, XVIVO’s Kidney Assist, a dedicated device for pressure controlled, oxygenated, ex vivo perfusion of donor kidneys. The Kidney Assist Transport is a portable device that allows hypothermic perfusion of donor kidneys with oxygenated solution for up to 24 hours. Thus, this will augment the segment growth in terms of share. However, a variety of diseases and conditions leading to lungs failure, such as COPD and others will drive the transplant demand for this segment. According to the World Health Organization (WHO), people with advanced stage COPD are highly exposed to the risk of lung failure requiring transplant. According to the International Society of Heart and Lung Transplantation, the total number of lung transplantation operation in the world is increasing year on year. The major factors, such as adoption of bad habits such as smoking, alcohol consumption, and others, unhealthy lifestyle and lack of physical activities can also lead to organ failure in long term. TransMedics developed an organ care system and stated that the system could effectively improve the organ's function even after the organ was removed from the donor body.
Various actions were also taken by government to raise awareness among people about organ donation and make it mandatory in order to reduce the shortage of organs. For instance, in 2017, France joined the list of countries that made organ donation mandatory after the death of a person. The new ‘presumed consent’ law assumed that the deceased person agrees to have their organs donated, even if the individual’s immediate family is against it.
A few of the key primary and secondary sources referred to while preparing the report on the organ care products market are the World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), International Diabetes Federation (IDF), Health Resources and Service Administration report, Global Observatory on Donation and Transplantation, and Global Burden of Disease (GBD).
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Transmedics
- Bridge T- Life Ltd
- Paragonix Technologies, Inc
- Organox Limited
- Waters Medical Systems LLC
- Organ Recovery Systems
- Accord Healthcare
- Dr. Franz Koehler Chemie GmbH
- Preservation Solutions, Inc.
- Xviv- Perfusion
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 158 |
| Published | March 2022 |
| Forecast Period | 2021 - 2028 |
| Estimated Market Value ( USD | $ 98.46 Million |
| Forecasted Market Value ( USD | $ 272.16 Million |
| Compound Annual Growth Rate | 15.6% |
| Regions Covered | Global |
